Mentoring and training the next generation of child neurology researchers is paramount to our continued growth and excellence as a field and as an academic community. Our trainees serve a vital role in the advancement of research and clinical practice. Recognition of our trainee's early successes is essential. Pediatric Neurology is proud to annually recognize outstanding science put forth by a first-author neurology/neurosurgery trainee (i.e., resident or fellow). The Pediatric Neurology Trainee Award Committee selects a single annual awardee. This award selection is based on several factors—including the importance of their scientific contribution, the quality of the presented research, and the overall manuscript preparation.
The award committee and journal's editors are pleased to announce the recipient of the 2021 Pediatric Neurology Trainee Publication Award: Jennifer C. Keene, MD, MS, MBA (Figure), from Seattle Children's Hospital for her article Pediatr Neurol. 2022 Jan; 126:50-55. doi: 10.1016/j.pediatrneurol.2021.10.001. Epub 2021 Oct 9. “Optimized Benzodiazepine Treatment of Pediatric Status Epilepticus through a Standardized Emergency Medical Services Resuscitation Tool.”
Dr. Keene and co-authors studied the use of an emergency medical services (EMS)–focused resuscitation aid on the appropriate dosing of benzodiazepines administered to children with out-of-hospital-onset status epilepticus. To accomplish this initiative, the research team collaborated with EMS medical directors to create a Medic One Pediatric (MOPed) length-based, color-coded dosage card that incorporated standard pediatric doses of medications utilized in pediatric status epilepticus. All county EMS providers underwent training on the use of these cards. The primary outcome was the percentage of children treated in the year prior to training (n = 44) who were underdosed with benzodiazepine compared to children treated within the year after MOPed training (n = 33). The percentage of children who were underdosed significantly decreased following MOPed training (52% pretraining vs 6% post-training; P < 0.001). However, there were no significant changes to the secondary hospital outcomes (i.e., time to second-line antiseizure medication, need for intubation, or intensive care unit admission).
These important findings highlight the feasibility of an EMS-focused intervention for pediatric status epilepticus. The sustainability of such an intervention will require further study. More importantly, their data indicate that optimizing out-of-hospital benzodiazepine dosing alone is not sufficient to impact important hospital outcomes in pediatric status epilepticus. In addition to optimizing benzodiazepine doses, work also must be done to improve access and reduce delays to second-line medications.
Congratulations Dr. Keene and colleagues on this excellent contribution to the growing field of research in the timely and effective treatment of pediatric status epilepticus.
Conflicts of interest and source of funding statement: The authors declare no conflict of interest or financial disclosures concerning the materials or methods used in this study or findings specified in this article.
© 2022 Published by Elsevier Inc.